Trial intelligence / Profile preview

Generic vs Brand 5-Fluorouracil for Actinic Keratosis

NCT01354717Phase 3Completed

Sponsor
Spear Pharmaceuticals
Start
Sep 2010
Primary completion
Mar 2011
Modality
Small Molecules
01

Overview

A Phase 3 trial of fluorouracil 5% cream in actinic keratosis (AK), sponsored by Spear Pharmaceuticals. Started Sep 2010; status: completed.

02

Drugs

fluorouracil 5% cream
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on NCT01354717.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01354717.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call